Inspired by the high frequency of aberrant DNA methylation occurrence in EBV‐associated cancers [16, 17], we analyzed the details of CDKN2A methylation status in all six CpG islands and revealed its diversity among different kinds of GCs (Figure 1D). The gene discussed is CDKN2A; the disease is cancer.